Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)

Kodiak Sciences (KOD) posted Liabilities and Shareholders Equity of $306.0 million for Q1 2026, down 12.95% on a QoQ basis from $351.5 million in Q4 2025, and up 2.72% year-over-year from $297.9 million in Q1 2025.

Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Kodiak Sciences' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $306.0 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 2.72% year-over-year to $306.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 19.56% YoY) and the FY2025 annual result came in at $351.5 million, up 4.75% from the prior year.
  • Liabilities and Shareholders Equity was $306.0 million for Q1 2026 at Kodiak Sciences, down from $351.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $850.3 million in Q1 2022 and bottomed at $218.1 million in Q3 2025.
  • A 5-year average of $485.6 million and a median of $434.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Peak annual rise in Liabilities and Shareholders Equity reached 4.75% in 2025, while the deepest fall reached 41.48% in 2025.
  • Kodiak Sciences' Liabilities and Shareholders Equity stood at $666.6 million in 2022, then slipped by 28.09% to $479.4 million in 2023, then dropped by 30.0% to $335.6 million in 2024, then grew by 4.75% to $351.5 million in 2025, then fell by 12.95% to $306.0 million in 2026.
  • Business Quant data shows KOD's Liabilities and Shareholders Equity at $306.0 million in Q1 2026, $351.5 million in Q4 2025, and $218.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Kodiak Sciences 2.54 Bn 2.54 Bn - 306.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 306.01 Mn
Dec 31, 2025 351.53 Mn
Sep 30, 2025 218.07 Mn
Jun 30, 2025 256.73 Mn
Mar 31, 2025 297.91 Mn
Dec 31, 2024 335.58 Mn
Sep 30, 2024 372.67 Mn
Jun 30, 2024 401.58 Mn
Mar 31, 2024 434.76 Mn
Dec 31, 2023 479.37 Mn
Sep 30, 2023 547.65 Mn
Jun 30, 2023 589.66 Mn
Mar 31, 2023 640.33 Mn
Dec 31, 2022 666.63 Mn
Sep 30, 2022 723.99 Mn
Jun 30, 2022 781.91 Mn
Mar 31, 2022 850.29 Mn
Dec 31, 2021 904.22 Mn
Sep 30, 2021 958.21 Mn
Jun 30, 2021 997.60 Mn